DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Mercure Hotel Amsterdam City

2019年12月04日 (水) 午前 8:00 - 2019年12月05日 (木) 午後 5:00

Joan Muyskenweg 10, 1096 CJ Amsterdam, Netherlands

Clinical Trial Disclosure & Data Transparency Conference

Evolving Requirements and New Challenges

Session 5: Transparency Implications of the EU Medical Device Regulations (MDR)

Session Chair(s)

Matthias  Zerm, PhD

Matthias Zerm, PhD

Lead Expert, Clinical Trial Disclosure and R&D Processes

Germany

The EU Medical Device Regulation (Regulation (EU) 2017/745) in conjunction with the upcoming new version of EN ISO 14155 introduces many new clinical trial disclosure and transparency requirements relating to clinical investigations with medical devices in the EU as from May 2020. The clinical module in Eudamed will serve as the central system for submitting, exchange of information, and reporting of clinical investigations and will be accessible to Regulatory Authorities, notified bodies, industry, and the public. Objectives: • Gain first hand insights on how information/documents relating to clinical investigations will be made publicly available in Eudamed: • What information/documents? • Publicly available at what point in time over the course of a clinical investigation? • What criteria and measures are foreseen to ensure protection of personal data and commercially confidential information potentially contained therein? • Learn about the new public disclosure provisions in the upcoming new version of EN ISO 14155:2018 and how they relate to the MDR and may become applicable beyond.

Speaker(s)

Celine  Bourguignon, PharmD, MPharm, MS

Industry View: Disclosure of clinical investigation information in Eudamed – what, when, how?”

Celine Bourguignon, PharmD, MPharm, MS

GSK, Belgium

Senior Director Regulatory Policy & Intelligence

Danielle  Giroud

New Version of ISO14155:2018

Danielle Giroud

World Medical Device Organization, Switzerland

Founder

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。